Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 AUD | -6.67% | -12.50% | -46.97% |
Apr. 23 | Australian Shares Rise on Business Activity Growth; Osteopore Soars 127% | MT |
Apr. 23 | Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194% | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
3D-printed Biomimetic and Bioresorbable Implants
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +31.02% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Singapore
51.4
%
| 2 | 100.0 % | 1 | 51.4 % | -32.61% |
South Korea
48.6
%
| - | - | 1 | 48.6 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Lim
CEO | Chief Executive Officer | - | 14-11-30 |
Ning Voon Shu
AUD | Comptroller/Controller/Auditor | - | - |
Kellie Davis
SEC | Corporate Secretary | - | 23-01-25 |
Khoon Seng Goh
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kei Wei Leong
CHM | Chairman | 49 | 21-07-31 |
Michael Keenan
BRD | Director/Board Member | - | 23-07-17 |
Swee Hin Teoh
BRD | Director/Board Member | - | 19-06-23 |
Daniel Ow
BRD | Director/Board Member | - | 21-10-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 113,615,579 | 109,527,462 ( 96.40 %) | 0 | 96.40 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-46.97% | 2.56M | |
-4.07% | 184B | |
-0.76% | 108B | |
-3.10% | 67.82B | |
+3.84% | 51.05B | |
+8.78% | 44.67B | |
+3.40% | 41.78B | |
+3.03% | 26.78B | |
+4.04% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- OSX Stock
- Company Osteopore Limited